4/14
08:30 am
clnn
Clene to Present at the Emerging Growth Conference
Medium
Report
Clene to Present at the Emerging Growth Conference
4/8
10:41 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
4/8
09:51 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
4/8
08:06 am
clnn
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session [Yahoo! Finance]
Medium
Report
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session [Yahoo! Finance]
4/8
08:00 am
clnn
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
Medium
Report
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
4/1
08:30 am
clnn
Clene to Present at the Jones Healthcare and Technology Innovation Conference
High
Report
Clene to Present at the Jones Healthcare and Technology Innovation Conference
3/24
03:16 pm
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
3/24
10:58 am
clnn
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights [Yahoo! Finance]
Low
Report
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights [Yahoo! Finance]
3/24
09:15 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
3/24
08:00 am
clnn
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights
Low
Report
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights
3/12
12:11 pm
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
3/12
08:36 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
3/12
08:00 am
clnn
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
Medium
Report
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
3/6
08:30 am
clnn
Clene to Present at the 37TH Annual Roth Conference
Medium
Report
Clene to Present at the 37TH Annual Roth Conference
2/25
12:08 pm
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
2/25
09:34 am
clnn
Clene and APST Enter Into an Agreement to Support FDA's Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®'s Impact on NfL Reduction [Yahoo! Finance]
Low
Report
Clene and APST Enter Into an Agreement to Support FDA's Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®'s Impact on NfL Reduction [Yahoo! Finance]
2/25
08:40 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
2/25
08:00 am
clnn
Clene and APST Enter Into an Agreement to Support FDA’s Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®’s Impact on NfL Reduction
Low
Report
Clene and APST Enter Into an Agreement to Support FDA’s Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®’s Impact on NfL Reduction
2/14
07:08 pm
clnn
Is Clene Inc. (CLNN) the Best Nanotech Penny Stock to Invest In? [Yahoo! Finance]
Medium
Report
Is Clene Inc. (CLNN) the Best Nanotech Penny Stock to Invest In? [Yahoo! Finance]
2/6
08:47 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
1/24
04:28 pm
clnn
Clene files to sell 1.15M shares of common stock by selling shareholders [Seeking Alpha]
Medium
Report
Clene files to sell 1.15M shares of common stock by selling shareholders [Seeking Alpha]